{"cik":1872356,"taxonomy":"us-gaap","tag":"Goodwill","label":"Goodwill","description":"Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.","entityName":"Molekule Group, Inc.","units":{"USD":[{"end":"2022-12-31","val":626647,"accn":"0001558370-23-005327","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-31"},{"end":"2022-12-31","val":626647,"accn":"0001558370-23-005401","fy":2022,"fp":"FY","form":"10-K/A","filed":"2023-04-03"},{"end":"2022-12-31","val":626647,"accn":"0001558370-23-009975","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15"},{"end":"2022-12-31","val":626647,"accn":"0001558370-23-014929","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-14","frame":"CY2022Q4I"},{"end":"2023-03-31","val":20680212,"accn":"0001558370-23-009975","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15","frame":"CY2023Q1I"},{"end":"2023-06-30","val":21031064,"accn":"0001558370-23-014929","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-14","frame":"CY2023Q2I"}]}}